New Onset of Vitiligo and Atopic Dermatitis-Like Eczematous Dermatitis After Pfizer BioNTech's BNT162b2 Vaccination

Eli Magen; Shaked Landman

doi:10.1097/der.0000000000000877

New Onset of Vitiligo and Atopic Dermatitis-Like Eczematous Dermatitis After Pfizer BioNTech's BNT162b2 Vaccination

Eli Magen, Shaked Landman

Faculty of Health Sciences

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	339-340
Number of pages	2
Journal	Dermatitis
Volume	34
Issue number	4
DOIs	https://doi.org/10.1097/der.0000000000000877
State	Accepted/In press - 1 Jan 2023

ASJC Scopus subject areas

Immunology and Allergy
Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/der.0000000000000877

Cite this

@article{ac5b6a6da8ed4942a78a7d8890c2bb91,

title = "New Onset of Vitiligo and Atopic Dermatitis-Like Eczematous Dermatitis After Pfizer BioNTech's BNT162b2 Vaccination",

author = "Eli Magen and Shaked Landman",

year = "2023",

month = jan,

day = "1",

doi = "10.1097/der.0000000000000877",

language = "English",

volume = "34",

pages = "339--340",

journal = "Dermatitis",

issn = "1710-3568",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "4",

}

TY - JOUR

T1 - New Onset of Vitiligo and Atopic Dermatitis-Like Eczematous Dermatitis After Pfizer BioNTech's BNT162b2 Vaccination

AU - Magen, Eli

AU - Landman, Shaked

PY - 2023/1/1

Y1 - 2023/1/1

UR - http://www.scopus.com/inward/record.url?scp=85162129067&partnerID=8YFLogxK

U2 - 10.1097/der.0000000000000877

DO - 10.1097/der.0000000000000877

M3 - Letter

C2 - 35481887

AN - SCOPUS:85162129067

SN - 1710-3568

VL - 34

SP - 339

EP - 340

JO - Dermatitis

JF - Dermatitis

IS - 4

ER -

New Onset of Vitiligo and Atopic Dermatitis-Like Eczematous Dermatitis After Pfizer BioNTech's BNT162b2 Vaccination

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this